Revised: 23 September 2022
Medicines
Policy Statements
| Date | Policy |
|---|---|
| 23 September 2022 | Medsafe policy for nitrosamine impurities in medicines – information for sponsors |
| 2020 | COVID-19 Policy Statements |
| 11 June 2018 | What to do in the case of a potential out of stock |
| 21 June 2017 | Change to Label Statement Database for OTC loratadine and desloratadine medicines |
| 18 April 2017 | Tips for changing to the new data sheet format |
| 19 October 2016 | Reminder to sponsors: Timeframes for provisional consent |
| 20 July 2015 | Changes to Priority Assessment Process |
| 28 May 2014 | Changes to the Definition of Medicines and Medical Devices Effective 1 July 2014 |
| 2 May 2014 | Biosimilars |
| 10 July 2013 | Subdividing of Tablets |
| 6 May 2013 | Electronic Submissions |
| 6 May 2013 | Proprietary Ingredients |
| 1 February 2013 | Update to Therapeutic Product Database Reports |
| February 2013 | Changing Registration Situation |
| January 2012 | Acceptability of Claims for Pain Relief |
| 1 March 2010 | Priority and Abbreviated Assessments |
